36 related articles for article (PubMed ID: 23788109)
1. Targeted disruption of the
Zeng J; Liang X; Duan L; Tan F; Chen L; Qu J; Li J; Li K; Luo D; Hu Z
Acta Biochim Biophys Sin (Shanghai); 2024 Apr; 56(4):525-537. PubMed ID: 38414349
[TBL] [Abstract][Full Text] [Related]
2. Lipopolymer mediated siRNA delivery targeting aberrant oncogenes for effective therapy of myeloid leukemia in preclinical animal models.
Ansari AS; K C R; Morales LC; Nasrullah M; Meenakshi Sundaram DN; Kucharski C; Jiang X; Brandwein J; Uludağ H
J Control Release; 2024 Mar; 367():821-836. PubMed ID: 38360178
[TBL] [Abstract][Full Text] [Related]
3. Targeted degradation of oncogenic BCR-ABL by silencing the gene of NEDD8 E3 ligase RAPSYN.
Sun Y; Wang Y; Liu C; Huang Y; Long Q; Ju C; Zhang C; Chen Y
J Nanobiotechnology; 2024 May; 22(1):247. PubMed ID: 38741123
[TBL] [Abstract][Full Text] [Related]
4. siRNA-mediated downregulation of BATF3 diminished proliferation and induced apoptosis through downregulating c-Myc expression in chronic myelogenous leukemia cells.
Dabbaghipour R; Khaze Shahgoli V; Safaei S; Amini M; Tabei S; Shanehbandi D; Rahbar Farzam O; Baradaran B; Entezam M
Mol Biol Rep; 2024 Jan; 51(1):100. PubMed ID: 38217769
[TBL] [Abstract][Full Text] [Related]
5. GFI1B and LSD1 repress myeloid traits during megakaryocyte differentiation.
Venhuizen J; van Bergen MGJM; Bergevoet SM; Gilissen D; Spruijt CG; Wingens L; van den Akker E; Vermeulen M; Jansen JH; Martens JHA; van der Reijden BA
Commun Biol; 2024 Mar; 7(1):374. PubMed ID: 38548886
[TBL] [Abstract][Full Text] [Related]
6. Cell-penetrating peptide and cationic liposomes mediated siRNA delivery to arrest growth of chronic myeloid leukemia cells in vitro.
Vysochinskaya V; Zabrodskaya Y; Dovbysh O; Emelyanov A; Klimenko V; Knyazev N; Terterov I; Egorova M; Bogdanov A; Maslov M; Vasin A; Dubina M
Biochimie; 2024 Jan; 221():1-12. PubMed ID: 38215931
[TBL] [Abstract][Full Text] [Related]
7. GFI1B acts as a metabolic regulator in hematopoiesis and acute myeloid leukemia.
Liu L; Patnana PK; Xie X; Frank D; Nimmagadda SC; Su M; Zhang D; Koenig T; Rosenbauer F; Liebmann M; Klotz L; Xu W; Vorwerk J; Neumann F; Hüve J; Unger A; Okun JG; Opalka B; Khandanpour C
Leukemia; 2022 Sep; 36(9):2196-2207. PubMed ID: 35804097
[TBL] [Abstract][Full Text] [Related]
8. Modified dendritic cell-derived exosomes activate both NK cells and T cells through the NKG2D/NKG2D-L pathway to kill CML cells with or without T315I mutation.
Du Z; Huang Z; Chen X; Jiang G; Peng Y; Feng W; Huang N
Exp Hematol Oncol; 2022 Jun; 11(1):36. PubMed ID: 35672796
[TBL] [Abstract][Full Text] [Related]
9. Organic Nanoparticles as Drug Delivery Systems and Their Potential Role in the Treatment of Chronic Myeloid Leukemia.
Hussein Kamareddine M; Ghosn Y; Tawk A; Elia C; Alam W; Makdessi J; Farhat S
Technol Cancer Res Treat; 2019; 18():1533033819879902. PubMed ID: 31865865
[TBL] [Abstract][Full Text] [Related]
10. Exosomes derived from siRNA against GRP78 modified bone-marrow-derived mesenchymal stem cells suppress Sorafenib resistance in hepatocellular carcinoma.
Li H; Yang C; Shi Y; Zhao L
J Nanobiotechnology; 2018 Dec; 16(1):103. PubMed ID: 30572882
[TBL] [Abstract][Full Text] [Related]
11. Interleukin 3- receptor targeted exosomes inhibit
Bellavia D; Raimondo S; Calabrese G; Forte S; Cristaldi M; Patinella A; Memeo L; Manno M; Raccosta S; Diana P; Cirrincione G; Giavaresi G; Monteleone F; Fontana S; De Leo G; Alessandro R
Theranostics; 2017; 7(5):1333-1345. PubMed ID: 28435469
[TBL] [Abstract][Full Text] [Related]
12. Transcription Factor GFI1B in Health and Disease.
Anguita E; Candel FJ; Chaparro A; Roldán-Etcheverry JJ
Front Oncol; 2017; 7():54. PubMed ID: 28401061
[TBL] [Abstract][Full Text] [Related]
13. Whole-Exome Sequencing Identifies Loci Associated with Blood Cell Traits and Reveals a Role for Alternative GFI1B Splice Variants in Human Hematopoiesis.
Polfus LM; Khajuria RK; Schick UM; Pankratz N; Pazoki R; Brody JA; Chen MH; Auer PL; Floyd JS; Huang J; Lange L; van Rooij FJ; Gibbs RA; Metcalf G; Muzny D; Veeraraghavan N; Walter K; Chen L; Yanek L; Becker LC; Peloso GM; Wakabayashi A; Kals M; Metspalu A; Esko T; Fox K; Wallace R; Franceschini N; Matijevic N; Rice KM; Bartz TM; Lyytikäinen LP; Kähönen M; Lehtimäki T; Raitakari OT; Li-Gao R; Mook-Kanamori DO; Lettre G; van Duijn CM; Franco OH; Rich SS; Rivadeneira F; Hofman A; Uitterlinden AG; Wilson JG; Psaty BM; Soranzo N; Dehghan A; Boerwinkle E; Zhang X; Johnson AD; O'Donnell CJ; Johnsen JM; Reiner AP; Ganesh SK; Sankaran VG
Am J Hum Genet; 2016 Aug; 99(2):481-8. PubMed ID: 27486782
[TBL] [Abstract][Full Text] [Related]
14. Viral/Nonviral Chimeric Nanoparticles To Synergistically Suppress Leukemia Proliferation via Simultaneous Gene Transduction and Silencing.
Hong CA; Cho SK; Edson JA; Kim J; Ingato D; Pham B; Chuang A; Fruman DA; Kwon YJ
ACS Nano; 2016 Sep; 10(9):8705-14. PubMed ID: 27472284
[TBL] [Abstract][Full Text] [Related]
15. Growth factor independence 1b (gfi1b) is important for the maturation of erythroid cells and the regulation of embryonic globin expression.
Vassen L; Beauchemin H; Lemsaddek W; Krongold J; Trudel M; Möröy T
PLoS One; 2014; 9(5):e96636. PubMed ID: 24800817
[TBL] [Abstract][Full Text] [Related]
16. New horizons for cancer gene therapy.
Libutti SK
Cancer Gene Ther; 2014 Jan; 21(1):1. PubMed ID: 24492767
[No Abstract] [Full Text] [Related]
17. Additive antileukemia effects by GFI1B- and BCR-ABL-specific siRNA in advanced phase chronic myeloid leukemic cells.
Koldehoff M; Zakrzewski JL; Beelen DW; Elmaagacli AH
Cancer Gene Ther; 2013 Jul; 20(7):421-7. PubMed ID: 23788109
[TBL] [Abstract][Full Text] [Related]
18. [Effect of specific siRNA targeting against bcr-abl chimeric gene on chronic myelogenous leukemia cells].
Wang S; Chai YB; Liu F; Zhang XY; Jia W; Xie X; Yu WQ; Shang ZC; Jin BQ; Sun BZ
Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(3):198-202. PubMed ID: 15854468
[TBL] [Abstract][Full Text] [Related]
19. WT1 and BCR-ABL specific small interfering RNA have additive effects in the induction of apoptosis in leukemic cells.
Elmaagacli AH; Koldehoff M; Peceny R; Klein-Hitpass L; Ottinger H; Beelen DW; Opalka B
Haematologica; 2005 Mar; 90(3):326-34. PubMed ID: 15749664
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
